“At present, the prevailing strategy for improving access to medicines for [neglected tropical diseases (NTDs)] is drug donation programs, which, despite providing some of the highest economic returns of public health programs … have uncertain sustainability,” Francesca Holt of St. John’s College at the University of Cambridge and colleagues write in this PLoS Neglected Tropical Diseases opinion piece. “Countries in demographic and economic transition are uniquely poised to be leaders in a shift towards a more sustainable, affordable means of providing access to medicines for NTDs,” they add, citing China, India, and Brazil as examples (2/28).